Share Price and Basic Stock Data
Last Updated: January 22, 2026, 11:15 pm
| PEG Ratio | 69.50 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dabur India Ltd, a prominent player in the personal care industry, reported a stock price of ₹518 and a market capitalization of ₹91,798 Cr. The company has demonstrated a consistent upward trend in sales, with total revenues reaching ₹11,530 Cr in FY 2023, an increase from ₹10,889 Cr in FY 2022. For the trailing twelve months (TTM), sales rose further to ₹12,781 Cr, indicating robust growth. Quarterly sales figures also reflected this trend, with the most recent quarter (Sep 2023) recording sales of ₹3,204 Cr, up from ₹2,986 Cr in Sep 2022. The company’s ability to maintain growth in a competitive market showcases its strong brand presence and product portfolio. However, quarterly fluctuations were evident, particularly in the March quarters, where sales dipped to ₹2,678 Cr in Mar 2023. This volatility may signal seasonal challenges or varying consumer demand, necessitating strategic responses to sustain growth.
Profitability and Efficiency Metrics
Dabur’s profitability metrics illustrate its operational strength, with a reported net profit of ₹1,782 Cr and a return on equity (ROE) of 17.0%. The operating profit margin (OPM) stood at 18%, reflecting effective cost management despite rising expenses. In the most recent quarter (Sep 2023), the OPM rose to 21%, indicating improved operational efficiency. The company’s interest coverage ratio (ICR) was reported at 17.53x, showcasing its ability to meet interest obligations comfortably. However, net profit margins have seen a decline from 16.01% in FY 2022 to 13.84% in FY 2025, suggesting that rising costs could be squeezing profitability. The cash conversion cycle (CCC) is notably strong at -14 days, indicating efficient inventory management and speedy receivables collection, which is advantageous in maintaining liquidity. Overall, while profitability remains solid, the decline in net profit margin warrants monitoring for potential impacts on future earnings.
Balance Sheet Strength and Financial Ratios
Dabur’s balance sheet reflects a strong financial position, with total assets reported at ₹16,230 Cr against total liabilities of ₹16,677 Cr, resulting in a manageable debt-to-equity ratio of 0.06. Borrowings increased to ₹1,301 Cr, up from ₹1,174 Cr in the previous year, indicating a strategic approach to leverage for growth. The company reported reserves of ₹10,781 Cr, providing a cushion for future investments and downturns. Furthermore, the price-to-book value (P/BV) ratio is at 8.31x, suggesting that the stock is trading at a premium relative to its book value, which may reflect market confidence in Dabur’s future earnings potential. The current ratio is reported at 1.51, indicating good short-term financial health. However, the increase in interest expenses, which rose to ₹164 Cr in FY 2025 from ₹39 Cr in FY 2022, may pose a risk to future profitability if not managed effectively.
Shareholding Pattern and Investor Confidence
Dabur’s shareholding pattern indicates a stable ownership structure, with promoters holding 66.22% of the company. Foreign institutional investors (FIIs) have seen a decline in their stake from 20.47% in Dec 2022 to 10.88% in Sep 2025, which may reflect a cautious stance from international investors amid market fluctuations. Conversely, domestic institutional investors (DIIs) have increased their stake to 17.29%, suggesting growing confidence among local investors. The number of shareholders has also decreased to 497,123, down from 510,298 in Dec 2024, indicating potential consolidation among smaller investors. The dividend payout ratio has increased to 55.14%, reflecting the company’s commitment to returning value to shareholders, although this high payout could limit reinvestment opportunities. Overall, the mix of stable promoter ownership and increasing DII participation suggests a balanced investor sentiment, but the decline in FII interest may raise questions about international confidence in the stock.
Outlook, Risks, and Final Insight
Looking forward, Dabur’s strong brand equity and diverse product range position it well for continued growth in the personal care sector. However, several risks remain, including increasing competition and rising input costs, which could pressure profit margins. The decline in net profit margins and the increasing interest expenses necessitate vigilant financial management to sustain profitability. Additionally, the volatility in quarterly sales highlights potential demand fluctuations, which could impact revenue stability. On the upside, effective cost management and enhanced operational efficiencies could bolster margins. The company’s strong reserve position provides a buffer for strategic investments, potentially enhancing growth prospects. Therefore, while Dabur India Ltd appears well-positioned for growth, it must navigate these challenges to maintain its competitive edge and ensure long-term shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 8,989 Cr. | 276 | 334/190 | 72.2 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 41.7 Cr. | 24.4 | 37.0/22.3 | 81.7 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 114 Cr. | 119 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 579 Cr. | 382 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 9,123 Cr. | 248 | 423/244 | 24.9 | 55.8 | 1.41 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,245.00 Cr | 1,870.16 | 58.27 | 112.70 | 0.76% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,986 | 3,043 | 2,678 | 3,130 | 3,204 | 3,255 | 2,815 | 3,349 | 3,029 | 3,355 | 2,830 | 3,405 | 3,191 |
| Expenses | 2,386 | 2,434 | 2,268 | 2,526 | 2,543 | 2,588 | 2,348 | 2,694 | 2,476 | 2,673 | 2,403 | 2,737 | 2,603 |
| Operating Profit | 600 | 609 | 410 | 605 | 661 | 667 | 466 | 655 | 553 | 682 | 427 | 667 | 588 |
| OPM % | 20% | 20% | 15% | 19% | 21% | 20% | 17% | 20% | 18% | 20% | 15% | 20% | 18% |
| Other Income | 123 | 101 | 121 | 110 | 117 | 127 | 129 | 129 | 152 | 129 | 141 | 144 | 140 |
| Interest | 15 | 19 | 32 | 24 | 28 | 36 | 35 | 33 | 47 | 44 | 39 | 35 | 40 |
| Depreciation | 70 | 71 | 102 | 97 | 98 | 97 | 107 | 109 | 111 | 109 | 117 | 114 | 115 |
| Profit before tax | 638 | 620 | 396 | 593 | 651 | 661 | 453 | 642 | 546 | 658 | 412 | 663 | 573 |
| Tax % | 23% | 23% | 26% | 23% | 22% | 23% | 25% | 23% | 24% | 22% | 24% | 23% | 22% |
| Net Profit | 491 | 477 | 293 | 457 | 507 | 506 | 341 | 494 | 418 | 516 | 313 | 508 | 445 |
| EPS in Rs | 2.77 | 2.69 | 1.70 | 2.62 | 2.91 | 2.90 | 1.97 | 2.82 | 2.40 | 2.95 | 1.81 | 2.90 | 2.55 |
Last Updated: January 2, 2026, 12:35 am
Below is a detailed analysis of the quarterly data for Dabur India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,405.00 Cr. (Jun 2025) to 3,191.00 Cr., marking a decrease of 214.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,603.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,737.00 Cr. (Jun 2025) to 2,603.00 Cr., marking a decrease of 134.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 588.00 Cr.. The value appears to be declining and may need further review. It has decreased from 667.00 Cr. (Jun 2025) to 588.00 Cr., marking a decrease of 79.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Jun 2025) to 18.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 140.00 Cr.. The value appears to be declining and may need further review. It has decreased from 144.00 Cr. (Jun 2025) to 140.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Jun 2025) to 40.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 115.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Jun 2025) to 115.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 573.00 Cr.. The value appears to be declining and may need further review. It has decreased from 663.00 Cr. (Jun 2025) to 573.00 Cr., marking a decrease of 90.00 Cr..
- For Tax %, as of Sep 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 23.00% (Jun 2025) to 22.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 508.00 Cr. (Jun 2025) to 445.00 Cr., marking a decrease of 63.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.55. The value appears to be declining and may need further review. It has decreased from 2.90 (Jun 2025) to 2.55, marking a decrease of 0.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:28 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,058 | 7,795 | 7,780 | 7,614 | 7,722 | 8,515 | 8,685 | 9,562 | 10,889 | 11,530 | 12,404 | 12,563 | 12,781 |
| Expenses | 5,897 | 6,475 | 6,261 | 6,102 | 6,104 | 6,775 | 6,892 | 7,560 | 8,637 | 9,367 | 10,004 | 10,247 | 10,417 |
| Operating Profit | 1,162 | 1,320 | 1,518 | 1,512 | 1,617 | 1,740 | 1,792 | 2,002 | 2,252 | 2,162 | 2,400 | 2,316 | 2,364 |
| OPM % | 16% | 17% | 20% | 20% | 21% | 20% | 21% | 21% | 21% | 19% | 19% | 18% | 18% |
| Other Income | 126 | 154 | 217 | 296 | 291 | 222 | 205 | 325 | 308 | 445 | 482 | 551 | 554 |
| Interest | 54 | 40 | 48 | 54 | 53 | 60 | 50 | 31 | 39 | 78 | 124 | 164 | 158 |
| Depreciation | 97 | 115 | 133 | 143 | 162 | 177 | 220 | 240 | 253 | 311 | 399 | 446 | 455 |
| Profit before tax | 1,136 | 1,319 | 1,554 | 1,611 | 1,693 | 1,725 | 1,728 | 2,056 | 2,269 | 2,219 | 2,359 | 2,258 | 2,305 |
| Tax % | 19% | 19% | 19% | 21% | 20% | 16% | 16% | 18% | 23% | 23% | 23% | 23% | |
| Net Profit | 916 | 1,068 | 1,254 | 1,280 | 1,358 | 1,446 | 1,448 | 1,695 | 1,742 | 1,701 | 1,811 | 1,740 | 1,782 |
| EPS in Rs | 5.24 | 6.07 | 7.11 | 7.25 | 7.69 | 8.17 | 8.18 | 9.58 | 9.84 | 9.64 | 10.40 | 9.97 | 10.21 |
| Dividend Payout % | 33% | 33% | 32% | 31% | 81% | 34% | 37% | 50% | 53% | 54% | 53% | 80% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.59% | 17.42% | 2.07% | 6.09% | 6.48% | 0.14% | 17.06% | 2.77% | -2.35% | 6.47% | -3.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.82% | -15.34% | 4.02% | 0.39% | -6.34% | 16.92% | -14.29% | -5.13% | 8.82% | -10.39% |
Dabur India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | -1% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | -1% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:08 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 174 | 176 | 176 | 176 | 176 | 177 | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
| Reserves | 2,482 | 3,178 | 3,995 | 4,671 | 5,530 | 5,455 | 6,429 | 7,487 | 8,205 | 8,796 | 9,689 | 10,623 | 10,781 |
| Borrowings | 708 | 734 | 805 | 975 | 938 | 699 | 522 | 509 | 1,030 | 1,174 | 1,365 | 950 | 1,301 |
| Other Liabilities | 1,948 | 2,019 | 1,956 | 1,910 | 2,058 | 2,106 | 2,209 | 2,661 | 2,872 | 3,505 | 3,885 | 4,479 | 4,417 |
| Total Liabilities | 5,312 | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,230 | 16,677 |
| Fixed Assets | 1,767 | 1,877 | 1,667 | 1,958 | 2,028 | 1,969 | 2,253 | 2,243 | 2,308 | 3,579 | 3,815 | 3,990 | 4,004 |
| CWIP | 22 | 50 | 45 | 42 | 42 | 64 | 147 | 147 | 168 | 175 | 232 | 169 | 125 |
| Investments | 1,076 | 1,813 | 2,691 | 3,240 | 3,805 | 3,359 | 2,800 | 4,160 | 6,220 | 6,265 | 6,933 | 7,468 | 7,596 |
| Other Assets | 2,447 | 2,365 | 2,529 | 2,492 | 2,827 | 3,045 | 4,137 | 4,283 | 3,589 | 3,633 | 4,136 | 4,603 | 4,951 |
| Total Assets | 5,312 | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,230 | 16,677 |
Below is a detailed analysis of the balance sheet data for Dabur India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 177.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 177.00 Cr..
- For Reserves, as of Sep 2025, the value is 10,781.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,623.00 Cr. (Mar 2025) to 10,781.00 Cr., marking an increase of 158.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,301.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 950.00 Cr. (Mar 2025) to 1,301.00 Cr., marking an increase of 351.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,417.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,479.00 Cr. (Mar 2025) to 4,417.00 Cr., marking a decrease of 62.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16,677.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16,230.00 Cr. (Mar 2025) to 16,677.00 Cr., marking an increase of 447.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,004.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,990.00 Cr. (Mar 2025) to 4,004.00 Cr., marking an increase of 14.00 Cr..
- For CWIP, as of Sep 2025, the value is 125.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 125.00 Cr., marking a decrease of 44.00 Cr..
- For Investments, as of Sep 2025, the value is 7,596.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,468.00 Cr. (Mar 2025) to 7,596.00 Cr., marking an increase of 128.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,951.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,603.00 Cr. (Mar 2025) to 4,951.00 Cr., marking an increase of 348.00 Cr..
- For Total Assets, as of Sep 2025, the value is 16,677.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,230.00 Cr. (Mar 2025) to 16,677.00 Cr., marking an increase of 447.00 Cr..
Notably, the Reserves (10,781.00 Cr.) exceed the Borrowings (1,301.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -707.00 | -733.00 | -804.00 | -974.00 | -937.00 | -698.00 | -521.00 | -507.00 | 1.00 | 1.00 | 1.00 | -948.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 33 | 38 | 31 | 33 | 36 | 34 | 21 | 22 | 27 | 26 | 26 |
| Inventory Days | 150 | 136 | 150 | 153 | 169 | 154 | 164 | 178 | 169 | 158 | 149 | 175 |
| Days Payable | 169 | 153 | 182 | 181 | 190 | 172 | 176 | 197 | 178 | 171 | 186 | 215 |
| Cash Conversion Cycle | 16 | 16 | 6 | 3 | 13 | 17 | 22 | 3 | 12 | 14 | -10 | -14 |
| Working Capital Days | -21 | -17 | -0 | -7 | -1 | -5 | 9 | -9 | -14 | -13 | -17 | -13 |
| ROCE % | 35% | 36% | 35% | 31% | 28% | 28% | 28% | 27% | 27% | 23% | 22% | 20% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 24,254,715 | 1.36 | 1254.94 | N/A | N/A | N/A |
| SBI Contra Fund | 18,846,663 | 1.96 | 975.13 | N/A | N/A | N/A |
| ICICI Prudential Value Fund | 12,226,667 | 1.05 | 632.61 | 14,380,825 | 2025-12-15 01:07:38 | -14.98% |
| HDFC Large Cap Fund | 6,885,831 | 0.88 | 356.27 | N/A | N/A | N/A |
| SBI Balanced Advantage Fund | 5,863,921 | 0.77 | 303.4 | N/A | N/A | N/A |
| ICICI Prudential Large & Mid Cap Fund | 4,152,710 | 0.8 | 214.86 | N/A | N/A | N/A |
| HDFC Hybrid Equity Fund | 3,670,973 | 0.77 | 189.94 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 3,109,139 | 0.21 | 160.87 | N/A | N/A | N/A |
| UTI Value Fund | 2,600,000 | 1.33 | 134.52 | N/A | N/A | N/A |
| Aditya Birla Sun Life Large Cap Fund | 2,597,331 | 0.43 | 134.39 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 9.97 | 10.40 | 9.64 | 9.84 | 9.58 |
| Diluted EPS (Rs.) | 9.95 | 10.38 | 9.61 | 9.81 | 9.55 |
| Cash EPS (Rs.) | 12.33 | 12.48 | 11.37 | 11.30 | 10.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 60.94 | 58.14 | 53.29 | 47.64 | 43.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 60.94 | 58.14 | 53.29 | 47.64 | 43.57 |
| Revenue From Operations / Share (Rs.) | 70.89 | 70.00 | 65.07 | 61.59 | 54.01 |
| PBDIT / Share (Rs.) | 16.17 | 16.27 | 14.73 | 14.97 | 13.17 |
| PBIT / Share (Rs.) | 13.66 | 14.01 | 12.97 | 13.54 | 11.81 |
| PBT / Share (Rs.) | 12.74 | 13.31 | 12.53 | 12.84 | 11.64 |
| Net Profit / Share (Rs.) | 9.82 | 10.22 | 9.61 | 9.87 | 9.60 |
| NP After MI And SOA / Share (Rs.) | 9.97 | 10.40 | 9.64 | 9.84 | 9.58 |
| PBDIT Margin (%) | 22.81 | 23.23 | 22.63 | 24.30 | 24.38 |
| PBIT Margin (%) | 19.26 | 20.02 | 19.93 | 21.98 | 21.86 |
| PBT Margin (%) | 17.96 | 19.02 | 19.25 | 20.85 | 21.54 |
| Net Profit Margin (%) | 13.84 | 14.60 | 14.76 | 16.01 | 17.76 |
| NP After MI And SOA Margin (%) | 14.07 | 14.85 | 14.80 | 15.97 | 17.73 |
| Return on Networth / Equity (%) | 16.36 | 18.67 | 19.02 | 20.75 | 22.09 |
| Return on Capital Employeed (%) | 20.31 | 22.18 | 22.88 | 26.71 | 26.38 |
| Return On Assets (%) | 10.88 | 12.18 | 12.50 | 14.15 | 15.61 |
| Long Term Debt / Equity (X) | 0.02 | 0.05 | 0.03 | 0.02 | 0.01 |
| Total Debt / Equity (X) | 0.06 | 0.11 | 0.11 | 0.10 | 0.06 |
| Asset Turnover Ratio (%) | 0.80 | 0.86 | 0.80 | 0.84 | 0.85 |
| Current Ratio (X) | 1.51 | 1.45 | 1.18 | 1.30 | 1.63 |
| Quick Ratio (X) | 0.98 | 0.94 | 0.61 | 0.72 | 1.04 |
| Inventory Turnover Ratio (X) | 5.92 | 2.61 | 2.22 | 2.17 | 2.21 |
| Dividend Payout Ratio (NP) (%) | 55.14 | 52.41 | 53.96 | 55.90 | 34.96 |
| Dividend Payout Ratio (CP) (%) | 44.04 | 43.07 | 45.65 | 48.80 | 30.62 |
| Earning Retention Ratio (%) | 44.86 | 47.59 | 46.04 | 44.10 | 65.04 |
| Cash Earning Retention Ratio (%) | 55.96 | 56.93 | 54.35 | 51.20 | 69.38 |
| Interest Coverage Ratio (X) | 17.53 | 23.21 | 33.35 | 68.57 | 75.56 |
| Interest Coverage Ratio (Post Tax) (X) | 11.64 | 15.59 | 22.77 | 48.39 | 56.05 |
| Enterprise Value (Cr.) | 90337.54 | 93630.67 | 97722.09 | 95194.73 | 94754.25 |
| EV / Net Operating Revenue (X) | 7.19 | 7.55 | 8.48 | 8.74 | 9.93 |
| EV / EBITDA (X) | 31.52 | 32.48 | 37.45 | 35.96 | 40.70 |
| MarketCap / Net Operating Revenue (X) | 7.15 | 7.47 | 8.38 | 8.71 | 10.01 |
| Retention Ratios (%) | 44.85 | 47.58 | 46.03 | 44.09 | 65.03 |
| Price / BV (X) | 8.31 | 9.40 | 10.76 | 11.32 | 12.47 |
| Price / Net Operating Revenue (X) | 7.15 | 7.47 | 8.38 | 8.71 | 10.01 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Dabur India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.97. This value is within the healthy range. It has decreased from 10.40 (Mar 24) to 9.97, marking a decrease of 0.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.95. This value is within the healthy range. It has decreased from 10.38 (Mar 24) to 9.95, marking a decrease of 0.43.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.33. This value is within the healthy range. It has decreased from 12.48 (Mar 24) to 12.33, marking a decrease of 0.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 60.94. It has increased from 58.14 (Mar 24) to 60.94, marking an increase of 2.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 60.94. It has increased from 58.14 (Mar 24) to 60.94, marking an increase of 2.80.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 70.89. It has increased from 70.00 (Mar 24) to 70.89, marking an increase of 0.89.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 16.17, marking a decrease of 0.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 13.66. This value is within the healthy range. It has decreased from 14.01 (Mar 24) to 13.66, marking a decrease of 0.35.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.74. This value is within the healthy range. It has decreased from 13.31 (Mar 24) to 12.74, marking a decrease of 0.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.82. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 9.82, marking a decrease of 0.40.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.97. This value is within the healthy range. It has decreased from 10.40 (Mar 24) to 9.97, marking a decrease of 0.43.
- For PBDIT Margin (%), as of Mar 25, the value is 22.81. This value is within the healthy range. It has decreased from 23.23 (Mar 24) to 22.81, marking a decrease of 0.42.
- For PBIT Margin (%), as of Mar 25, the value is 19.26. This value is within the healthy range. It has decreased from 20.02 (Mar 24) to 19.26, marking a decrease of 0.76.
- For PBT Margin (%), as of Mar 25, the value is 17.96. This value is within the healthy range. It has decreased from 19.02 (Mar 24) to 17.96, marking a decrease of 1.06.
- For Net Profit Margin (%), as of Mar 25, the value is 13.84. This value exceeds the healthy maximum of 10. It has decreased from 14.60 (Mar 24) to 13.84, marking a decrease of 0.76.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.07. This value is within the healthy range. It has decreased from 14.85 (Mar 24) to 14.07, marking a decrease of 0.78.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.36. This value is within the healthy range. It has decreased from 18.67 (Mar 24) to 16.36, marking a decrease of 2.31.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.31. This value is within the healthy range. It has decreased from 22.18 (Mar 24) to 20.31, marking a decrease of 1.87.
- For Return On Assets (%), as of Mar 25, the value is 10.88. This value is within the healthy range. It has decreased from 12.18 (Mar 24) to 10.88, marking a decrease of 1.30.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.02, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.11 (Mar 24) to 0.06, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has decreased from 0.86 (Mar 24) to 0.80, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.51, marking an increase of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.94 (Mar 24) to 0.98, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.92. This value is within the healthy range. It has increased from 2.61 (Mar 24) to 5.92, marking an increase of 3.31.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.14. This value exceeds the healthy maximum of 50. It has increased from 52.41 (Mar 24) to 55.14, marking an increase of 2.73.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 44.04. This value is within the healthy range. It has increased from 43.07 (Mar 24) to 44.04, marking an increase of 0.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.86. This value is within the healthy range. It has decreased from 47.59 (Mar 24) to 44.86, marking a decrease of 2.73.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 55.96. This value is within the healthy range. It has decreased from 56.93 (Mar 24) to 55.96, marking a decrease of 0.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.53. This value is within the healthy range. It has decreased from 23.21 (Mar 24) to 17.53, marking a decrease of 5.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.64. This value is within the healthy range. It has decreased from 15.59 (Mar 24) to 11.64, marking a decrease of 3.95.
- For Enterprise Value (Cr.), as of Mar 25, the value is 90,337.54. It has decreased from 93,630.67 (Mar 24) to 90,337.54, marking a decrease of 3,293.13.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.19. This value exceeds the healthy maximum of 3. It has decreased from 7.55 (Mar 24) to 7.19, marking a decrease of 0.36.
- For EV / EBITDA (X), as of Mar 25, the value is 31.52. This value exceeds the healthy maximum of 15. It has decreased from 32.48 (Mar 24) to 31.52, marking a decrease of 0.96.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.15. This value exceeds the healthy maximum of 3. It has decreased from 7.47 (Mar 24) to 7.15, marking a decrease of 0.32.
- For Retention Ratios (%), as of Mar 25, the value is 44.85. This value is within the healthy range. It has decreased from 47.58 (Mar 24) to 44.85, marking a decrease of 2.73.
- For Price / BV (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has decreased from 9.40 (Mar 24) to 8.31, marking a decrease of 1.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.15. This value exceeds the healthy maximum of 3. It has decreased from 7.47 (Mar 24) to 7.15, marking a decrease of 0.32.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dabur India Ltd:
- Net Profit Margin: 13.84%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.31% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.36% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 51.5 (Industry average Stock P/E: 58.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.84%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | 8/3, Asaf Ali Road, New Delhi Delhi 110002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mohit Burman | Chairman & Non-Exe.Director |
| Mr. Saket Burman | Vice Chairman & Non Exe.Dire |
| Mr. P D Narang | Whole Time Director |
| Mr. Mohit Malhotra | WholeTime Director & CEO |
| Mr. Aditya Burman | Non Executive Director |
| Mr. Amit Burman | Non Executive Director |
| Mr. Mukesh Butani | Lead Independent Director |
| Mr. Ajit Mohan Sharan | Independent Director |
| Mr. Rajiv Mehrishi | Independent Director |
| Mrs. Satyavati Berera | Independent Director |
| Mr. Romesh Sobti | Independent Director |
| Mr. Ravi Kapoor | Independent Director |
FAQ
What is the intrinsic value of Dabur India Ltd?
Dabur India Ltd's intrinsic value (as of 23 January 2026) is ₹442.69 which is 15.68% lower the current market price of ₹525.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹93,226 Cr. market cap, FY2025-2026 high/low of ₹577/420, reserves of ₹10,781 Cr, and liabilities of ₹16,677 Cr.
What is the Market Cap of Dabur India Ltd?
The Market Cap of Dabur India Ltd is 93,226 Cr..
What is the current Stock Price of Dabur India Ltd as on 23 January 2026?
The current stock price of Dabur India Ltd as on 23 January 2026 is ₹525.
What is the High / Low of Dabur India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dabur India Ltd stocks is ₹577/420.
What is the Stock P/E of Dabur India Ltd?
The Stock P/E of Dabur India Ltd is 51.5.
What is the Book Value of Dabur India Ltd?
The Book Value of Dabur India Ltd is 61.8.
What is the Dividend Yield of Dabur India Ltd?
The Dividend Yield of Dabur India Ltd is 1.52 %.
What is the ROCE of Dabur India Ltd?
The ROCE of Dabur India Ltd is 20.2 %.
What is the ROE of Dabur India Ltd?
The ROE of Dabur India Ltd is 17.0 %.
What is the Face Value of Dabur India Ltd?
The Face Value of Dabur India Ltd is 1.00.